Sildenafil Citrate Patent Expiration
Sildenafil Citrate was first introduced by Viatris Specialty Llc
Sildenafil Citrate Patents
Given below is the list of patents protecting Sildenafil Citrate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Liqrev | US11337979 | Liquid oral formulations for sildenafil | Dec 24, 2038 | Cmp Dev Llc |
| Liqrev | US11464778 | Liquid oral formulations for sildenafil | Dec 24, 2038 | Cmp Dev Llc |
| Liqrev | US11759468 | Liquid oral formulations for sildenafil | Dec 24, 2038 | Cmp Dev Llc |
| Liqrev | US12005062 | Liquid oral formulations for sildenafil | Dec 24, 2038 | Cmp Dev Llc |
| Liqrev | US12186321 | Liquid oral formulations for sildenafil | Dec 24, 2038 | Cmp Dev Llc |
| Viagra |
US6469012 (Pediatric) | Pyrazolopyrimidinones for the treatment of impotence |
Apr 22, 2020
(Expired) | Viatris |
| Viagra | US6469012 | Pyrazolopyrimidinones for the treatment of impotence |
Oct 22, 2019
(Expired) | Viatris |
| Revatio |
US5250534 (Pediatric) | Pyrazolopyrimidinone antianginal agents |
Sep 27, 2012
(Expired) | Viatris |
| Viagra |
US5250534 (Pediatric) | Pyrazolopyrimidinone antianginal agents |
Sep 27, 2012
(Expired) | Viatris |
Sildenafil Citrate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List